Please assess the completion status of the following clinical trial:

Trial Title: Retrospective Study of Trabectedin in Soft Tissue Sarcomas

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients who received trabectedin according to the approved indication in the period January 2010 December 2015~Exclusion Criteria:~* Trabectedin started before January 2010 and after December 2015~* Participation into clinical trials with trabectedin~* Clinical chart missing, empty, or not retrievable.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Trabectedin (Type: None): Trabectedin give according the market authorization for advanced soft tissue sarcoma

Based on this trial design, predict the completion outcome and termination type (if applicable).